CVG:FRA
중국제약
€0.94
arrow_downward
-2.96%(-0.029) 1D
4월 27일, 오전 8시 6분 50초 GMT+2 · EUR
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoCVG의 주요 통계 생성 중...
시가
€0.94
고가
€0.94
저가
€0.94
시가총액
1015.13억
평균 거래량
307.00
거래량
0.00
52주 최고가
€1.25
52주 최저가
€0.63
직원 수
2만
뉴스 기사
웹 소스 기반
프로필
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
중국제약에 관한 정보